Inflammation and cancer: Is trophism the link?

Surgical Oncology

Volumn 15, Issue 4, 2006, Pages 235-242

  Arias, Jose Ignacio ^a   Aller, Maria Angeles ^b   Sánchez Patan, Fernando ^b   Arias, Jaime ^a  

^a Monte Naranco Hospital   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Aging; Cancer; Inflammation; Trophism

Indexed keywords

ANGIOGENESIS; CANCER; CAPILLARY; CARCINOGENESIS; EDEMA; ENDOCRINE FUNCTION; GLYCOLYSIS; HUMAN; INFLAMMATION; ISCHEMIA; LEUKOCYTE; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; MEDIATOR RELEASE; NUTRITION; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; REPERFUSION; REVASCULARIZATION; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WOUND HEALING;

ANOXIA; GLYCOLYSIS; HUMANS; INFLAMMATION; NEOPLASMS; OXIDATIVE STRESS; PHENOTYPE; RISK FACTORS;

EID: 34248636214     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2007.02.001     Document Type: Review

References (68)

1. Tu S.M., Lin S.H., and Logothetis C.J. Stem-cell origin of metastasis and heterogeneity in solid tumors. Lancet Oncol 3 8 (2002) 508-513
2. Bruce C., Osman N., Audisio R.A., and Aapro M.S. European school of oncology advanced course on cancer in the elderly. Liverpool, 29-30 April 2004. Surg Oncol 13 4 (2004) 159-167
3. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 1 (2000) 57-70
4. Gospodarowicz M.K., Miller D., Groome P.A., Greene F.L., Logan P.A., and Sobin L.H. The process for continuous improvement of the TNM classification. Cancer 100 1 (2004) 1-5
5. Aller M.A., Arias J.L., Nava M.P., and Arias J. Posttraumatic inflammation is a complex response based on the pathological expression of the nervous, immune and endocrine functional systems. Exp Biol Med (Maywood) 229 2 (2004) 170-181
6. Aller M.A., Arias J.L., and Arias J. Post-traumatic inflammatory response: perhaps a succession of phases with a nutritional purpose. Med Hypotheses 63 1 (2004) 42-46
7. Arias J.L., Aller M.A., and Arias J. The use of inflammation by tumor cells. Cancer 104 2 (2005) 223-228
8. Balkwill F., and Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 357 9255 (2001) 539-545
9. Farrow B., and Evers B.M. Inflammation and the development of pancreatic cancer. Surg Oncol 10 4 (2002) 153-169
10. Schwartsburd P.M. Chronic inflammation as inductor of pro-cancer microenvironment: pathogenesis of dysregulated feedback control. Cancer Metastasis Rev 22 1 (2003) 95-102
11. Ben-Baruch A. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Semin Cancer Biol 16 1 (2006) 38-52
12. Cines D.B., Pollak E.S., Buck C.A., Loscalzo J., Zimmerman G.A., McEver R.P., et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91 10 (1998) 3527-3561
13. Splettstoesser W.D., and Schuff-Werner P. Oxidative stress in phagocytes "The enemy within". Microsc Res Tech 57 6 (2002) 441-455
14. Sherwood E.R., and Toliver-Kinsky T. Mechanism of the inflammatory response. Best Pract Res Clin Anaesth 18 3 (2004) 385-405
15. Clarke J.H., Cha J.Y., Walsh M.D., Harken A.H., and McCarter M.D. Dendritic cells as therapeutic adjuncts in surgical disease. Surgery 138 5 (2005) 844-850
16. Frantz S., Vincent K.A., Feron O., and Kelly R.A. Innate immunity and angiogenesis. Circ Res 96 1 (2005) 15-26
17. Monaco J.L., and Lawrence T. Acute wound healing. An overview. Clin Plastic Surg 30 1 (2003) 1-12
18. Aller M.A., Arias J.L., Nava M.P., and Arias J. Evolutive trophic phases of the systemic acute inflammatory response, oxygen use mechanisms and metamorphosis. Psicothema 16 3 (2004) 369-372
19. Mareel M., and Leroy A. Clinical, cellular and molecular aspects of cancer invasion. Physiol Rev 83 2 (2003) 337-376
20. Arias J, Arias JI, Aller MA. Regarding the need for a metabolic staging of cancer (eLetter). CA Cancer J Clin 2005, 〈http://caonline.amcancersoc.org/cgi/eletters/54/6/295〉.
21. Denko N.C., Fontana L.A., and Hudson K.M. Investigating hypoxic tumor physiology through gene expresión patterns. Oncogene 22 37 (2003) 5907-5914
22. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 6917 (2002) 860-867
23. Marx J. Inflammation and cancer: the link grows stronger. Science 306 5698 (2004) 966-968
24. Nathanson S.D. Insights into the mechanisms of lymph node metastasis. Cancer 98 2 (2003) 413-423
25. Naresh K.N., Nerurkar A.Y., and Borges A.M. Angiogenesis is a redundant for tumor growth in lymph node metastases. Histopathology 38 5 (2001) 466-470
26. Harlozinska A. Progress in molecular mechanisms of tumor metastasis and angiogenesis. Anticancer Res 25 5 (2005) 3327-3334
27. Miller S.J., Lavker R.M., and Sun T.-T. Interpreting epithelial cancer biology in the context of stem cells: tumor properties and therapeutic implications. Biochim Biophys Acta 1756 1 (2005) 25-52
28. Welsh S.J., and Powis G. Hypoxia inducible factor as a cancer drug target. Curr Cancer Drug Targets 3 6 (2003) 391-405
29. Michiels C. Physiological and pathological responses to hypoxia. Am J Pathol 164 6 (2004) 1875-1882
30. Ashrafian H. Cancer's sweet tooth: the Janus effect of glucose metabolism in tumorigenesis. Lancet 367 9510 (2006) 618-621
31. Bamias A., and Dimopoulos M.A. Angiogenesis in human cancer: implications in cancer therapy. Eur J Intern Med 14 8 (2003) 459-469
32. Hornebeck W., Emonard H., Monboisse J.C., and Bellon G. Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin Cancer Biol 12 3 (2002) 231-241
33. Hornebeck W., and Birembaut P. Introduction: stroma reaction and cancer progression. Crit Rev Oncol Hematol 49 3 (2004) 177-178
34. Schmidt-Kittler O., Ragg T., and Daskalakis A. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci USA 100 13 (2003) 7737-7742
35. Shevde L.A., and Welch D.R. Metastasis supressor pathways evolving paradigm. Canter Lett 198 1 (2003) 1-20
36. Bogenrieder T., and Herlyn M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22 42 (2003) 6524-6536
37. McCord J.M. Oxygen-derived free radicals in postischemic tissue injury. New Engl J Med 312 3 (1985) 159-163
38. Nathan C. Points of control in inflammation. Nature 420 6917 (2002) 846-852
39. Hanada T., and Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev 13 4-5 (2002) 413-421
40. Pikarsky E., Porat R., Stein I., Abramovitch R., Amit S., Kasem S., et al. NF-κB functions as a tumor promoter in inflammation-associated cancer. Nature 431 7007 (2004) 461-466
41. Balkwill F., and Coussens L.M. An inflammatory link. Nature 431 7007 (2004) 405-406
42. Philip M., Rowley D.A., and Schreiber H. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 14 6 (2004) 433-439
43. Li Q., Withoff S., and Verma I.M. Inflammation-associated cancer: NF-κB is the lynchpin. Trends Immunol 26 5 (2005) 318-325
44. Nickoloff B.J., Ben-Neriah Y., and Pikarsky E. Inflammation and cancer: is the link as simple as we think?. J Invest Dermatol 124 6 (2005) x-xiv
45. Tazawa H., Okada F., Kobayashi T., Tada M., Mori Y., Une Y., et al. Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells. Implication of inflammation-associated carcinogenesis and tumor progression. Am J Pathol 163 6 (2003) 2221-2232
46. Samoszuk M., Deng T., Hamamura M.J., Su M.-Y., Asbrock N., and Nalcioglu O. Increased blood clotting, microvascular density, and inflammation in eotaxin-secreting tumors implanted into mice. Am J Pathol 165 2 (2004) 449-456
47. Houghton J.M., Stoicov C., Nomura S., Rogers A.B., Carlson J., Li H., et al. Gastric cancer originating from bone marrow-derived cells. Science 306 5701 (2004) 1568-1571
48. Baniyash M. Chronic inflammation, immunosuppression and cancer: new insights and outlook. Semin Cancer Biol 16 2 (2006) 80-88
49. Engbring J.A., and Kleinman H.K. The basement membrane matrix in malignancy. J Pathol 200 4 (2003) 465-470
50. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.T., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 6824 (2001) 50-56
51. Al-Rawi M.A.A., Mansel R.E., and Jiang W.G. Lymphangiogenesis and its role in cancer. Histol Histopathol 20 1 (2005) 283-298
52. Skobe M., Hawighorst J., and Jackson D.G. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7 2 (2001) 192-198
53. Nathan C. Oxygen and the inflammatory cell. Nature 422 6993 (2003) 675-676
54. Sitkovsky M.V., Lukashev D., Apasov S., Kojima H., Koshiba M., Caldwell C., et al. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Ann Rev Immunol 22 (2004) 657-682
55. Hammerman P.S., Fox C.J., and Thompson C.B. Beginnings of a signal-transduction pathway for bioenergetic control of cell survival. Trends Biochem Sci 29 11 (2004) 586-592
56. Manka D., and Millhorn D.E. A potential molecular link between aerobic glycolysis and cancer. Cell Cycle 5 4 (2006) 343-344
57. Naresh K.N., Nerurkar A.Y., and Borges A.M. Angiogenesis is a redundant for tumor growth in lymph node metastases. Histopathology 38 5 (2001) 466-470
58. Pantel K., and Woelfle U. Detection and molecular characterisation of diseminated tumor cells: Implications for anticancer therapy. Biochim Biophys Acta 1756 1 (2005) 53-64
59. Braun S., Kentenich C., Janni W., Hepp F., De Waal J., Willgeroth F., et al. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol 18 1 (2000) 80-86
60. Deans C., and Wigmore S.J. Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care 8 3 (2005) 265-269
61. Delano M.J., and Moldawer L.L. The origins of cachexia in acute and chronic inflammatory diseases. Nutr Clin Pract 21 1 (2006) 68-81
62. Shiota G. The hypothesis of Warburg revisited: a metabolic switch in carcinogenesis. Hepatol Res 36 3 (2006) 156-157
63. Argiles J.M., Busquets S., Felipe A., and Lopez-Soriano F.J. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia. Int J Biochem Cell Biol 37 5 (2005) 1084-1104
64. Gentaby R.A., and Gawlinski E.T. The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. Cancer Res 63 14 (2003) 3847-3854
65. Martignoni ME, Kunze P, Firess H. Cancer cachexia. Mol Cancer 2003;2:36, 〈http://www.molecular-cancer.com/content/2/I/36〉.
66. Baniyash M. The inflammation-cancer linkage: a double-edged sword?. Semin Cancer Biol 16 1 (2006) 1-2
67. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann NY Acad Sci 908 (2000) 244-254
68. Caruso C., Lio D., Cavallone L., and Franceschi C. Aging, longevity, inflammation, and cancer. Ann NY Acad Sci 1028 (2004) 1-13